Financials
Board Changes | 31-May-2023 | 07:00 | RNS |
PDS Business Update and First Quarter Results | 15-May-2023 | 15:16 | RNS |
Glycotest, Inc. Fundraising | 02-May-2023 | 07:00 | RNS |
Business Update | 03-Apr-2023 | 07:00 | RNS |
PDS Update | 30-Mar-2023 | 15:51 | RNS |
PDS Business Update and 2022 Financial Results | 28-Mar-2023 | 15:50 | RNS |
Related party loan to ProAxsis Limited | 28-Feb-2023 | 07:00 | RNS |
PDS completes FDA meeting for triple combination | 27-Feb-2023 | 15:28 | RNS |
Second Price Monitoring Extn | 10-Feb-2023 | 14:05 | RNS |
Price Monitoring Extension | 10-Feb-2023 | 14:00 | RNS |
Second Price Monitoring Extn | 10-Feb-2023 | 11:05 | RNS |
Price Monitoring Extension | 10-Feb-2023 | 11:00 | RNS |
Board Change | 01-Feb-2023 | 07:00 | RNS |
PDS Announces Exclusive Global License Agreement | 03-Jan-2023 | 13:31 | RNS |
PDS Biotech: Median Overall Survival announcement | 28-Dec-2022 | 15:05 | RNS |
Currency | UK Pounds |
Share Price | 51.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 76.50 |
52 Week Low | 49.00 |
Volume | 1,147 |
Shares Issued | 24.36m |
Market Cap | £12.54m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:27 | 171 @ 50.22p |
10:13 | 976 @ 50.80p |
You are here: research